CRO

Search documents
益诺思发布上市后首份年报:2024年营收达11.42亿元 归母净利润为1.48亿元
Zheng Quan Ri Bao Wang· 2025-04-30 02:48
公司还积极加速构建"AI+"能力,聚焦人工智能与产业场景的深度融合,积极探索研发基于深度学习的 智能病理辅助诊断系统,通过AI智能辅助分析为临床决策提供精准支撑。 本报讯(记者金婉霞)4月29日晚间,上海益诺思生物技术股份有限公司(下称"益诺思")披露2024年度报 告。数据显示,2024年,公司实现营业收入为11.42亿元,同比增长9.94%;归母净利润为1.48亿元,扣 非净利润为1.25亿元。 分业务来看,益诺思非临床CRO业务(合同研究组织,为医药企业提供包括新药产品开发、临床前研究 及临床试验、数据管理、新药申请等技术服务)实现营收10.89亿元,同比增长8.99%;其中,安全性服 务实现收入9.59亿元,同比增长7.86%。另外,公司临床CRO业务实现营业收入4693.85万元,同比增长 27.17%。 新签订单方面,2024年,益诺思新签订单金额为8.19亿元,截至2024年末在手订单金额为9.73亿元;此 外,据同日披露的2025年一季报,益诺思在新药临床试验申请和新药上市申请这两个阶段的新签订单个 数合计同比增长18.37%。 自设立以来,益诺思凭借自身具有的前瞻性、创新性能力,逐步形成了重 ...
FMC Corporation announces election of Steven Merkt to Board of Directors
Prnewswire· 2025-04-29 20:30
Core Viewpoint - FMC Corporation has elected Steven Merkt to its Board of Directors, effective April 29, 2025, to enhance its strategic growth initiatives in the agricultural sciences sector [1][2]. Company Overview - FMC Corporation is a global agricultural sciences company focused on providing solutions for food, feed, fiber, and fuel production while adapting to environmental changes [4]. - The company emphasizes innovation in crop protection solutions, including biologicals, crop nutrition, and digital agriculture, to help growers tackle challenges economically and sustainably [4]. Leadership Appointment - Steven Merkt brings over 30 years of experience in international manufacturing, operational excellence, cybersecurity, and corporate governance [2][3]. - His previous role as president of the Transportation Solutions segment at TE Connectivity from 2012 to 2024 involved significant profitability growth and the development of a robust innovation pipeline [2]. - Merkt has held senior leadership positions in various sectors, including automotive, and has experience in managing complex Board governance issues [3]. Strategic Goals - The addition of Merkt to the Board is expected to provide valuable insights and leadership as FMC aims to strengthen its position as a global leader in agricultural sciences [2]. - Merkt expressed his commitment to accelerating FMC's mission and driving growth while ensuring operational excellence [4].
Dell Technologies Stock Trading at Big Discount: Should You Buy, Sell or Hold?
ZACKS· 2025-04-29 20:00
Dell Technologies (DELL) shares are cheap, as suggested by a Value Score of B. The DELL stock is trading at a significant discount with a forward 12-month P/E of 11.51X compared with the Computer and Technology sector's 23.15X. P/E Ratio (Forward 12 Months) Image Source: Zacks Investment Research YTD DELL Stock Price Performance Image Source: Zacks Investment Research The recent drop in the share price is largely due to broader market weakness. Investor sentiment has soured amid rising trade tension, with a ...
益诺思2024年营收11.42亿元 同比增9.94%
Zheng Quan Shi Bao Wang· 2025-04-29 16:17
Group 1 - The company achieved a revenue of 1.142 billion yuan in 2024, representing a year-on-year growth of 9.94% [2] - The net profit attributable to shareholders was 148 million yuan, with a non-recurring net profit of 125 million yuan [2] - The revenue growth was primarily driven by the core business segment of safety services, which generated 959 million yuan, a year-on-year increase of 7.86% [2] Group 2 - The company faced pressure on profit margins due to a slowdown in investment and market demand in the domestic pharmaceutical industry, leading to intensified market competition and a decline in sales order prices [2] - The company has developed several core technology platforms, including toxicological biomarker evaluation and non-clinical safety evaluation systems, and has assisted in nearly 200 innovative drug research services [2] - The company is actively building "AI+" capabilities, focusing on the integration of artificial intelligence with industry scenarios, and is exploring the development of AI-assisted diagnostic systems [3] Group 3 - The company's subsidiary passed the FDA's Good Laboratory Practice (GLP) inspection, enhancing its international service capabilities [3] - The company ranks among the top three in the domestic non-clinical safety evaluation market, indicating a leading position in the industry [3] - Recent government policies supporting innovative drug development and the CRO industry are expected to provide significant growth opportunities for the company [3]
AML Go Showcased at MFSA’s Virtual Workshop: Mastering FICA Compliance
Globenewswire· 2025-04-29 11:07
Core Insights - AML Go (Pty) Ltd, a subsidiary of UPAY Inc., presented at the MicroFinance South Africa (MFSA) Virtual Workshop on FICA Compliance, highlighting its role in AML compliance solutions [1][5] - The workshop attracted over 380 delegates, including compliance officers and representatives from the Financial Intelligence Centre, focusing on practical insights for the credit and microfinance sector [2][3] AML Go's Contributions - AML Go demonstrated its intelligent compliance engine, showcasing how it simplifies regulatory processes for accountable institutions in the microfinance sector [4] - The company emphasizes the importance of technology-enabled compliance tools to meet regulatory standards effectively [3][5] Industry Context - The workshop addressed key areas of the Financial Intelligence Centre Act (FICA), including Risk Management and Compliance Programs, Customer Due Diligence, and employee screening procedures [8] - There is a growing need for automated solutions that can perform client screening, risk profiling, and generate audit-friendly reports [9]
Aurora Mobile’s SendCloud Partners with DHgate to Power Seamless Customer Communication
Globenewswire· 2025-04-29 09:00
Core Insights - Aurora Mobile's subsidiary SendCloud has successfully supported DHgate during a significant increase in U.S. users, helping it achieve the 2 position on the U.S. App Store Free iPhone Apps Ranking, only behind ChatGPT [1][4] Company Overview - Aurora Mobile, founded in 2011, is a leading provider of customer engagement and marketing technology services in China, focusing on stable and efficient messaging services [7] - DHgate, established in 2004, is a prominent Chinese cross-border B2B marketplace that connects global buyers with Chinese manufacturers for small-batch wholesale [2] Industry Trends - The surge in DHgate's popularity in the U.S. emphasizes the importance of direct connections between Chinese factories and international consumers, facilitating easier access to goods [3] - The growth of Chinese cross-border e-commerce highlights the necessity for seamless, AI-powered customer engagement solutions to succeed in dynamic international markets [5] Technological Capabilities - SendCloud's robust API integration allowed DHgate to manage increased user load effectively, maintaining stable customer communication and fostering customer loyalty [4] - EngageLab, leveraging SendCloud's infrastructure, provides advanced customer engagement solutions tailored for global e-commerce challenges, supporting businesses in over 220 countries and regions [6][8] Performance Metrics - Aurora Mobile boasts over 90% email deliverability, a 99% inbox placement rate, and a 40% email open rate, significantly outperforming industry benchmarks [7]
20亿!宏禧科技硅基OLED微型显示模组生产基地在安徽开工
WitsView睿智显示· 2025-04-29 05:52
【LEDinside】 4月28日,宏禧科技全资子公司安徽宏禧微显科技有限公司举行了硅基OLED微型 显示模组(一期)项目的开工仪式,项目总投资20亿元,将建设高端数字化智能制造基地。 图片来源:宏禧科技 宏禧科技成立于2019年7月,专注于硅基Micro OLED微型显示器及模组的研发、设计与制造。公 司已建成一条12英寸硅基Micro OLED生产线,已推出0.6英寸、0.7英寸、1.33英寸产品,并在开 发1.4英寸(4K×4K)新型号。 此外,国际厂商也在加速推进相关技术。1月,韩媒ETNews报道称,三星显示旗下的Micro OLED 企业eMagin已收到RGB Micro OLED工程样品订单,计划于2025年第二季度开始量产。 市场新品方面,4月国兆光电发布了0.3英寸超高亮低功耗硅基OLED显示屏,创王光电则推出了亮 度高达6万nits的最新Micro OLED产品。 #宏禧科技 #硅基OLED #MicroOLED 今年2月,宏禧科技完成近5亿元A轮融资,由安徽省智能家电家居产业基金、国芯创投等机构参 投。 值得一提的是,除了宏禧科技外,行业内其他企业也在加快硅基OLED领域的布局。 3月 ...
诺思格:Q1收入略有下滑,利润增速稳健-20250429
Tai Ping Yang· 2025-04-29 04:10
Investment Rating - The report maintains a "Buy" rating for the company, with a target price based on the last closing price of 44.46 [1][6]. Core Insights - In Q1 2025, the company reported a slight decline in revenue of 2.53% year-on-year, totaling 173 million yuan, while net profit increased by 13.12% to 26 million yuan. The growth in profit is attributed to cost reduction and efficiency improvements [4][5]. - The company is expanding its overseas business, establishing subsidiaries in Hong Kong and Australia, which is expected to accelerate its international presence. Additionally, favorable policies in the healthcare sector may lead to a recovery in the domestic clinical CRO industry [6][5]. - The company forecasts revenue growth from 777 million yuan in 2025 to 966 million yuan in 2027, with corresponding net profits expected to rise from 147 million yuan to 181 million yuan during the same period [7][6]. Summary by Sections Financial Performance - Q1 2025 revenue was 173 million yuan, down 2.53% year-on-year, while net profit was 26 million yuan, up 13.12%. The adjusted net profit was 20 million yuan, reflecting a 23.26% increase [4][5]. - The company's expense ratios improved, with management expenses decreasing by 4.06 percentage points to 11.58%, and sales expenses down by 0.08 percentage points to 1.88%. The gross margin was 36.53%, a decrease of 1.31 percentage points year-on-year, while the net margin increased by 1.99 percentage points to 15.28% [5][6]. Business Outlook - The company is expected to maintain steady growth in its SMO business, while its statistical business remains stable. However, clinical and testing services have seen a decline [5]. - The revenue projections for 2025 to 2027 indicate a compound annual growth rate (CAGR) of 4.42%, 9.53%, and 13.47%, respectively, with net profit growth rates of 4.58%, 9.72%, and 12.46% [6][7]. Valuation Metrics - The projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 30, 27, and 24, respectively, indicating a favorable valuation outlook as the company grows [6][7].
这个板块领涨
第一财经· 2025-04-29 04:06
2025.04. 29 微信编辑 | 生产队的驴(午休版) 推荐阅读 多地宣布发钱奖励结婚! 截至午盘,上证指数报3287.45点,跌0.03%,深成指报9863.9点,涨0.09%,创业板指报1935.35 点,涨0.05%。PEEK材料概念股爆发,宠物经济、人形机器人、CRO、医美、固态电池、消费电 子、AI算力题材涨幅居前;电力股大幅调整,白酒、统一大市场、零售、免税店概念股走弱。 机构观点 中泰证券投顾邓天认为,目前市场处于修复阶段,预计大盘仍可能延续盘整。在操作上,随着年报、 季报陆续公布,个股不确定性大大降低,活跃资金有望重获定价权。短线可关注科技板块是否有技术 突破和基本面改善。长线可增配基建、光伏、军工等低估资产。 前海波本基金有限公司投资总监晋军认为,市场强势攀升趋势不改,料关税争端尘埃落定前,中期市 场或延续其强劲韧性。短期指数运行至前期3319至3288重压区域难免承压,但节前市场无忧。待一 季报集中披露期后,尤其是节后补缺完成,应加强防范短期回落风险。 作者 | 第一财经 ...
成都思科瑞微电子股份有限公司 2025年第一季度报告
Zheng Quan Ri Bao· 2025-04-29 01:54
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688053 证券简称:思科瑞 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假 记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的,以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目,应说明原因。 □适用 √不适用 (三) 主要会计数据、财务指标发生变动的情况、原因 持股5%以上 ...